Sb-Kawasumi Laboratories, Inc.

Sb-Kawasumi Laboratories, Inc. — FDA 510(k) Submissions

Sb-Kawasumi Laboratories, Inc. has submitted 5 FDA 510(k) premarket notifications since 2022, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Tubes, Vials, Systems, Serum Separators, Blood Collection, Unit, Electrosurgical, Endoscopic (with Or Without Accessories), Non-coring (huber) Needle . Use the specialty filter in the sidebar to narrow results.